STOKE THERAPEUTICS INC shareholders Q3 2023

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 99 filers reported holding STOKE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.

STOKE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Skorpios Trust 14,443,681$56,908,10399.78%
Lynx1 Capital Management LP 1,710,154$6,738,0074.46%
COWEN AND COMPANY, LLC 3,721,659$14,663,3361.03%
Redmile Group, LLC 3,872,696$15,258,4220.73%
RTW INVESTMENTS, LP 4,390,558$17,298,7990.36%
Birchview Capital, LP 85,000$334,9000.28%
Cormorant Asset Management, LP 1,087,807$4,285,9600.25%
Granahan Investment Management 851,201$3,353,7320.12%
GSA CAPITAL PARTNERS LLP 348,069$1,3710.12%
Simplify Asset Management Inc. 102,985$405,7610.05%
Fort Point Capital Partners LLC 75,429$297,1900.04%
Baker Brothers Advisors 1,485,915$5,854,5050.03%
Corton Capital Inc. 14,749$58,1110.03%
Ikarian Capital, LLC 500$197,0000.02%
Virtus ETF Advisers LLC 7,893$31,0980.02%
SHERBROOKE PARK ADVISERS LLC 12,295$48,4420.02%
Trexquant Investment LP 127,581$502,6690.01%
Ikarian Capital, LLC 12,116$47,7360.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 217,605$857,3640.01%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 239,300$942,8420.00%
External links

This page lists STOKE THERAPEUTICS INC's shareholders in Q3 2023. To view STOKE THERAPEUTICS INC's shareholder history, click here.